Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 7/20 | 0.77 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.47 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2777605 | 0.99 | PNP (0.75) | PNPFGFR1FGFR2 | |
| Sulfuric Acid SCHEMBL17186613 | 0.94 | PNP (0.68) | PNPFGFR1FGFR2 | |
| SCHEMBL2777879 | 0.89 | PNP (0.74) | PNPFGFR1FGFR2 | |
| SCHEMBL3303807 | 0.89 | PNP (0.77) | PNPFGFR1FGFR2 | |
| Hydrochloric Acid SCHEMBL2775954 | 0.88 | PNP (0.72) | PNPFGFR1FGFR2 | |
| SCHEMBL3021038 | 0.87 | PNP (0.75) | PNPFGFR1FGFR2 | |
| SCHEMBL3308558 | 0.87 | PNP (0.75) | PNPFGFR1FGFR2 | |
| SCHEMBL1533546 | 0.87 | PNP (0.75) | PNP | |
| SCHEMBL3310268 | 0.87 | PNP (0.75) | PNPFGFR1FGFR2 | |
| Hydrochloric Acid SCHEMBL17186489 | 0.87 | PNP (0.75) | PNPFGFR1FGFR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160230011-A1 | CELL PERMEABLE, FLUORESCENT DYE | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2016-08-11 | — | — | US | disclosed |
| US-8623627-B2 | Labelling of fusion proteins with synthetic probes | NEW ENGLAND BIOLABS, INC (US) | 2014-01-07 | — | — | US | disclosed |
| US-20130130291-A1 | Labelling of Fusion Proteins with Synthetic Probes | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2013-05-23 | — | — | US | disclosed |
| EP-2049499-B1 | LABELLING OF FUSION PROTEINS WITH SYNTHETIC PROBES | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2012-10-31 | — | — | EP | disclosed |
| US-20120237961-A1 | Labelling of Fusion Proteins with Synthetic Probes | GAUTIER ARNAUD (CH) | 2012-09-20 | — | — | US | disclosed |
| US-8227602-B2 | Labelling of fusion proteins with synthetic probes | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2012-07-24 | — | — | US | disclosed |
| US-20110207157-A1 | Labelling of Fusion Proteins With Synthetic Probes | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2011-08-25 | — | — | US | disclosed |
| US-20110165593-A1 | Mutants of 06-Alkylguanine-DNA Alkyltransferase | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2011-07-07 | — | — | US | disclosed |
| US-7888090-B2 | reduced DNA interaction; localization of the expressed protein in eukaryotic cells that is no longer restricted to the nucleus; improved expression yield as soluble protein and improved stability in various hosts; oxidizing resistant;better in vitro solubility | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2011-02-15 | — | — | US | disclosed |
| US-20110014196-A1 | Drug Transfer into Living Cells | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20070207532-A1 | Mutants Of O6-Alkylguanine-Dna Alkyltransferase | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2007-09-06 | — | — | US | disclosed |
| US-20060292651-A1 | Protein labelling with oº-alkylguanine-dna alkyltrnsferase | ECOLE POLYTECHNIQUE FEDERAL DE LAUSANNE (EPFL) (CH) | 2006-12-28 | — | — | US | disclosed |
| EP-1720981-A2 | MUTANTS OF O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL Ecole Polytechnique Fédérale de Lausanne (CH) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005085431-A9 | MUTANTS OF O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL ECOLE POLYTECHNIQUE FEDERALE LAUSANNE (CH) | 2006-10-12 | — | — | WO | disclosed |
| US-20060024775-A1 | Substrates for o6-alkylguanina-dna alkyltransferase | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL). (CH) | 2006-02-02 | — | — | US | disclosed |
| WO-2005085431-A2 | MUTANTS OF O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2005-09-15 | — | — | WO | disclosed |
| EP-1546371-A1 | SUBSTRATES FOR O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2005-06-29 | — | — | EP | disclosed |
| EP-1546370-A1 | PROTEIN LABELLING WITH O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004031404-A1 | PROTEIN LABELLING WITH O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2004-04-15 | — | — | WO | disclosed |
| WO-2004031405-A1 | SUBSTRATES FOR O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2004-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110014196-A1 | Drug Transfer into Living Cells | TSPO, MPI, ABCB1 | PNP 112/4885FGFR1 1000/4885FGFR2 2330/4885 |
| US-20160230011-A1 | CELL PERMEABLE, FLUORESCENT DYE | EPCAM, IK, TSPO | PNP 4748/4885FGFR1 2991/4885FGFR2 2624/4885 |
| US-20110207157-A1 | Labelling of Fusion Proteins With Synthetic Probes | GART, ALKBH2, ATIC | PNP 132/4885FGFR1 2838/4885FGFR2 2385/4885 |
| US-20060024775-A1 | Substrates for o6-alkylguanina-dna alkyltransferase | AGT, OGG1, NUDT1 | PNP 176/4885FGFR1 2992/4885FGFR2 3601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.